Provision Precision Medicine: Theranostics
Welcome to Provision Theranostics Center
Provision is a leader in the next generation of precision medicine for cancer treatment. Our theranostic procedures are FDA-approved combination of pairs of radiopharmaceuticals that “diagnosis” and “treat” a particular disease. This offers a unique approach to targeting cancer at a molecular level. Pluvicto (lutetium Lu 177 vipivotide tetraxetan) is available at Provision Theranostics Center, for the treatment of PSMA-positive metastatic castration-resistant prostate cancer (mCRPC).
